Characteristics of study subjects included in the diagnosis phase, by province
| CHARACTERISTIC | BRITISH COLUMBIA, 2007 TO 2011, N (%)* (N = 14 198) | MANITOBA, 2007 TO 2012, N (%)* (N = 4216) | ONTARIO, 2007 TO 2012, N (%)* (N = 46 966) |
|---|---|---|---|
| Age group, y | |||
| • < 40 | 577 (4.1) | 190 (4.5) | 2801 (6.0) |
| • 40–49 | 2355 (16.6) | 636 (15.1) | 7722 (16.4) |
| • 50–59 | 3407 (24.0) | 1009 (23.9) | 11 807 (25.1) |
| • 60–69 | 3641 (25.6) | 1078 (25.6) | 11 734 (25.0) |
| • 70–74 | 1369 (9.6) | 388 (9.2) | 4423 (9.4) |
| • > 74 | 2849 (20.1) | 915 (21.7) | 8479 (18.1) |
| Comorbidity, ADGs | |||
| • 0–3 | 4559 (32.1) | 995 (23.6) | 12 392 (26.4) |
| • 4–5 | 3449 (24.3) | 948 (22.5) | 10 698 (22.8) |
| • 6–7 | 2790 (19.7) | 861 (20.4) | 9916 (21.1) |
| • 8–9 | 1832 (12.9) | 682 (16.2) | 7023 (15.0) |
| • ≥ 10 | 1568 (11.0) | 730 (17.3) | 6937 (14.8) |
| Stage at diagnosis | |||
| • I | 5966 (42.0) | 1706 (40.5) | 17 475 (37.2) |
| • II | 4550 (32.0) | 1582 (37.5) | 16 610 (35.4) |
| • III | 1803 (12.7) | 601 (14.3) | 6110 (13.0) |
| • IV | 597 (4.2) | 259 (6.1) | 2059 (4.4) |
| • Missing | 1282 (9.0) | 68 (1.6) | 4712 (10.0) |
ADG—Johns Hopkins Aggregated Diagnosis Group.
↵* Percentages might not add to 100 owing to rounding.